多发性红细胞症的心肌肥大:病例报告和文献综述。

IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS World Journal of Cardiology Pub Date : 2024-11-26 DOI:10.4330/wjc.v16.i11.651
Bai-Sheng Ma, Shu-Hui Zhai, Wei-Wei Chen, Qi-Ni Zhao
{"title":"多发性红细胞症的心肌肥大:病例报告和文献综述。","authors":"Bai-Sheng Ma, Shu-Hui Zhai, Wei-Wei Chen, Qi-Ni Zhao","doi":"10.4330/wjc.v16.i11.651","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The combination of polycythemia vera (PV) with pathological cardiac hypertrophy is uncommon. In this study, we describe a case of PV accompanied by pathological cardiac hypertrophy. It is hypothesized that the pronounced cardiac hypertrophy in this patient has a strong connection with PV.</p><p><strong>Case summary: </strong>In 2021, a 34-year-old Chinese man experienced chest constriction, shortness of breath, and palpitations during vigorous activity. Each episode lasted several minutes and resolved spontaneously following cessation of vigorous activity. He occasionally experienced syncope and vertigo without a headache. He underwent cardiac magnetic resonance imaging and was diagnosed with \"hypertrophic cardiomyopathy (HCM)\". He was discharged after receiving symptomatic treatment, which resulted in an improvement. He presented to our department with chest constriction, shortness of breath, and respiratory distress for one month while climbing to the second floor in 2023. His blood pressure was 180/100 mmHg at the time of admittance, and he was receiving antihypertensive treatment. He had a history of PV for 2 years without treatment. Symptomatic treatment was implemented concurrently with the administration of hydroxyurea upon admission. Good blood pressure control was observed during the long-term follow-up, and echocardiography did not reveal any progression of myocardial hypertrophy.</p><p><strong>Conclusion: </strong>Clinicians managing PV patients should remain highly vigilant regarding the risks of thrombosis and cardiovascular complications, particularly in those with refractory hypertension.</p>","PeriodicalId":23800,"journal":{"name":"World Journal of Cardiology","volume":"16 11","pages":"651-659"},"PeriodicalIF":1.9000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586724/pdf/","citationCount":"0","resultStr":"{\"title\":\"Cardiac hypertrophy in polycythemia vera: A case report and review of literature.\",\"authors\":\"Bai-Sheng Ma, Shu-Hui Zhai, Wei-Wei Chen, Qi-Ni Zhao\",\"doi\":\"10.4330/wjc.v16.i11.651\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The combination of polycythemia vera (PV) with pathological cardiac hypertrophy is uncommon. In this study, we describe a case of PV accompanied by pathological cardiac hypertrophy. It is hypothesized that the pronounced cardiac hypertrophy in this patient has a strong connection with PV.</p><p><strong>Case summary: </strong>In 2021, a 34-year-old Chinese man experienced chest constriction, shortness of breath, and palpitations during vigorous activity. Each episode lasted several minutes and resolved spontaneously following cessation of vigorous activity. He occasionally experienced syncope and vertigo without a headache. He underwent cardiac magnetic resonance imaging and was diagnosed with \\\"hypertrophic cardiomyopathy (HCM)\\\". He was discharged after receiving symptomatic treatment, which resulted in an improvement. He presented to our department with chest constriction, shortness of breath, and respiratory distress for one month while climbing to the second floor in 2023. His blood pressure was 180/100 mmHg at the time of admittance, and he was receiving antihypertensive treatment. He had a history of PV for 2 years without treatment. Symptomatic treatment was implemented concurrently with the administration of hydroxyurea upon admission. Good blood pressure control was observed during the long-term follow-up, and echocardiography did not reveal any progression of myocardial hypertrophy.</p><p><strong>Conclusion: </strong>Clinicians managing PV patients should remain highly vigilant regarding the risks of thrombosis and cardiovascular complications, particularly in those with refractory hypertension.</p>\",\"PeriodicalId\":23800,\"journal\":{\"name\":\"World Journal of Cardiology\",\"volume\":\"16 11\",\"pages\":\"651-659\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-11-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11586724/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4330/wjc.v16.i11.651\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4330/wjc.v16.i11.651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景:多发性红细胞增多症(PV)合并病理性心脏肥大并不常见。在本研究中,我们描述了一例红细胞增多症伴有病理性心脏肥大的病例。病例摘要:2021 年,一名 34 岁的中国男子在剧烈运动时出现胸闷、气短和心悸。每次发作持续数分钟,并在停止剧烈活动后自行缓解。他偶尔会出现晕厥和眩晕,但没有头痛。他接受了心脏磁共振成像检查,被诊断为 "肥厚型心肌病(HCM)"。在接受对症治疗后,他的病情有所好转并出院。2023 年,他因爬二楼时胸闷、气短和呼吸困难一个月而到我科就诊。入院时血压为 180/100 mmHg,正在接受降压治疗。他曾有过 PV 病史 2 年,未接受过治疗。入院时在对症治疗的同时还服用了羟基脲。长期随访观察到血压控制良好,超声心动图检查未发现任何心肌肥厚进展:结论:管理中风患者的临床医生应对血栓形成和心血管并发症的风险保持高度警惕,尤其是难治性高血压患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Cardiac hypertrophy in polycythemia vera: A case report and review of literature.

Background: The combination of polycythemia vera (PV) with pathological cardiac hypertrophy is uncommon. In this study, we describe a case of PV accompanied by pathological cardiac hypertrophy. It is hypothesized that the pronounced cardiac hypertrophy in this patient has a strong connection with PV.

Case summary: In 2021, a 34-year-old Chinese man experienced chest constriction, shortness of breath, and palpitations during vigorous activity. Each episode lasted several minutes and resolved spontaneously following cessation of vigorous activity. He occasionally experienced syncope and vertigo without a headache. He underwent cardiac magnetic resonance imaging and was diagnosed with "hypertrophic cardiomyopathy (HCM)". He was discharged after receiving symptomatic treatment, which resulted in an improvement. He presented to our department with chest constriction, shortness of breath, and respiratory distress for one month while climbing to the second floor in 2023. His blood pressure was 180/100 mmHg at the time of admittance, and he was receiving antihypertensive treatment. He had a history of PV for 2 years without treatment. Symptomatic treatment was implemented concurrently with the administration of hydroxyurea upon admission. Good blood pressure control was observed during the long-term follow-up, and echocardiography did not reveal any progression of myocardial hypertrophy.

Conclusion: Clinicians managing PV patients should remain highly vigilant regarding the risks of thrombosis and cardiovascular complications, particularly in those with refractory hypertension.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
World Journal of Cardiology
World Journal of Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.30%
发文量
54
期刊最新文献
Cardiac arrest: Pre-hospital strategies to facilitate successful resuscitation and improve recovery rates. Demographic trends in mortality with older population due to atrial fibrillation and flutter from 1999-2020. Global hotspots and trends on environmental exposure and cardiovascular disease from 1999 to 2022. Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling. Known yet underdiagnosed: Invasive assessment of coronary microvascular disease and its implications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1